Venture Fund Targets Data-Driven Health Technologies | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Venture Fund Targets Data-Driven Health Technologies

March 19, 2017
by David Raths
| Reprints
Seattle-based Biomatics to invest in 15 to 20 startups

Seattle-based Biomatics Capital Partners, a venture capital firm focused on genomics, digital health and data-driven healthcare technologies, has announced the closing of its initial fund of $200 million, in excess of its target of $150 million.

Biomatics focuses on advancing academic research and early-stage health care innovation to commercialization. The firm estimates that it will invest in 15 to 20 companies through this fund, acting as Series A lead investor in a majority of the deals. Initial investments typically range from $5 million to $10 million, with up to $20 million over the life of the investment.

Leading its team are managing directors Boris Nikolic, M.D., and Julie Sunderland, who have invested together in emerging technology, healthcare and life science ventures since 2010. Once they have invested, they take an active role with portfolio companies, supporting startups with hiring, intellectual property, regulatory issues and exit strategy.  

In a prepared statement, Nikolic, who previously served as chief advisor for science and technology to Bill Gates, said the healthcare ecosystem is at a tipping point. "In the next decade, breakthrough science and technology will fundamentally transform the practice of medicine and delivery of healthcare. Data will drive this transformation."

Prior to co-founding Biomatics with Dr. Nikolic in 2016, Sunderland was director of Program Related Investments for the Bill & Melinda Gates Foundation. "By combining the best of science with sound investment practices, we are looking to create extraordinary financial value for our investors and a pathway to better patient outcomes,” she said in a statement.  

Biomatics' current portfolio includes: 

• AiCure (medication adherence powered by artificial intelligence)

• Aledade (data-driven business model for accountable health care) 

• BlackThorn Therapeutics (informatics-driven drug discovery) 

• Blue Talon (enterprise-level data security for health care) 

• Denali Therapeutics (next-gen therapeutics for neurodegenerative diseases)

• GRAIL (genomics-based cancer screening)

• Omniome (low-cost DNA sequencing platform)

• Twist Bioscience (synthetic DNA)

 

Topics

News

Allscripts Acknowledges Ransomware Attack, Says Impact is “Limited”

Health IT vendor Allscripts has acknowledged that it is investigating a ransomware incident that has impacted a limited number of its applications.

AHRQ to Fund Patient Safety Learning Laboratories

The federal Agency for Healthcare Research Quality plans to spend up to $5 million in fiscal 2018 to support as many as eight patient safety learning laboratories.

RCM Global Software Market to Hit $43.3B by 2022, Report Finds

The global market for healthcare revenue cycle management software is estimated to reach $43.3 billion by the end of 2022, according to a report from Future Market Insights (FMI).

Global Open Source HIT Project Gets $1M Donation From Cryptocurrency Philanthropy

OpenMRS, Inc., an open source medical records platform used in developing countries, has received a $1 million donation from the Pineapple Fund, an $86 million cryptocurrency philanthropy created by an anonymous donor known only as “Pine.”

Media Reports: Massive Data Breach of Norwegian Health Authority Could Impact 3 Million Patients

International media outlets are reporting that a hacker or hacker group breached the systems of Norway’s Health South East EHF, potentially compromising the healthcare data of nearly 3 million patients, or about half of Norway’s population.

Healthcare Groups Call for Improvements to Prior Authorization Process

A collaborative of healthcare organizations, including the American Medical Association, the American Hospital Association, and the Medical Group Management Association, released a joint statement this week calling for improved prior authorization procedures, including automating the process to improve transparency and efficiency.